Literature DB >> 15564887

HLA-B*5701 and abacavir hypersensitivity.

Maria E Watson, Jeanne M Pimenta, William R Spreen, Jaime E Hernandez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15564887     DOI： 10.1097/00008571-200411000-00011

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN： 0960-314X


× No keyword cloud information.
  3 in total

Review 1.  Understanding genomics: implications for the emergency medicine physician and the treatment of asthma.

Authors:  Robert J Freishtat; Stephen J Teach
Journal:  Pediatr Emerg Care       Date:  2006-01       Impact factor: 1.454

Review 2.  Pharmacoeconomic evaluations of pharmacogenetic and genomic screening programmes: a systematic review on content and adherence to guidelines.

Authors:  Stefan Vegter; Cornelis Boersma; Mark Rozenbaum; Bob Wilffert; Gerjan Navis; Maarten J Postma
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

3.  Safety analysis of Epzicom® (lamivudine/abacavir sulfate) in post-marketing surveillance in Japan.

Authors:  Tomoko Kurita; Tomomi Kitaichi; Takako Nagao; Toshiyuki Miura; Yoshifumi Kitazono
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-03-03       Impact factor: 2.890
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.